The Abu Dhabi Investment Authority (ADIA) and Micro Life Sciences Private Limited (Meril) have made a pact that involves an investment amounting to USD 200 million.

A wholly owned subsidiary of ADIA has agreed to invest the huge sum for about 3% stake in Meril.

The globally-diversified investment institution, ADIA, and one of India’s established medical devices companies Meril have agreed upon this transaction subject to regulatory approval by the Competition Commission of India (CCI).

With this investment, Meril’s enterprise value soars to USD 6.6 billion.

As a global innovator in medical technology, Meril provides clinically advanced solutions across multiple specialties. – editor@nrifocus.com